Length of Pro Medicus's Contracts Looks Positive -- Market Talk

Dow Jones
06/01

0442 GMT - The length of Pro Medicus's new contracts is seen as good news at RBC Capital Markets. Analyst Jackson Lee reminds investors that TidalHealth agreed to a seven-year contract, and that Allegheny stuck to a five-year term for its renewal. He writes in a note to clients that the duration of both represents a step forward in debunking the widespread narrative over AI disruption. Lee writes that neither company has shown signs of seeking a shorter-term contract, which would have kept open the option of exploring AI native alternatives. RBC has a sector-perform rating and A$195.00 target price on the stock, which is up 8.1% at A$142.95. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 01, 2026 00:42 ET (04:42 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10